We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Five years after proposing a rule that would have given generic drug makers responsibility for their own drug labels—a move that would have exposed them to more lawsuits—the FDA has changed its mind.
Five years after proposing a rule that would have given generic drug makers responsibility for their own drug labels—a move that would have exposed them to more lawsuits—the FDA has changed its mind.
Dr Scott Gottlieb highlighted how brand reference drug companies voluntarily withdraw their marketing applications and stopped updating their labelling…